NovoCure Ltd Insider Trading for November 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for November 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 96.04 | 16,223 | 1,558,057 | 643,242 | 659.5 K to 643.2 K (-2.46 %) |
| Nov 26 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Option Exercise | M | 22.00 | 103,000 | 2,266,000 | 310,910 | |
| Nov 26 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 95.00 | 103,000 | 9,785,000 | 134,601 | 237.6 K to 134.6 K (-43.35 %) |
| Nov 26 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Buy | M | 22.00 | 103,000 | 2,266,000 | 237,601 | 134.6 K to 237.6 K (+76.52 %) |
| Nov 26 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 20,000 | 140,600 | 19,214 | |
| Nov 26 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 95.00 | 20,000 | 1,900,000 | 69,504 | 89.5 K to 69.5 K (-22.35 %) |
| Nov 26 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 20,000 | 140,600 | 89,504 | 69.5 K to 89.5 K (+28.78 %) |
| Nov 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 20,000 | 140,600 | 39,214 | |
| Nov 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 90.00 | 20,000 | 1,800,000 | 69,504 | 89.5 K to 69.5 K (-22.35 %) |
| Nov 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 20,000 | 140,600 | 89,504 | 69.5 K to 89.5 K (+28.78 %) |
| Nov 22 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 91.01 | 700 | 63,707 | 659,465 | 660.2 K to 659.5 K (-0.11 %) |
| Nov 22 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 90.36 | 149,300 | 13,490,016 | 660,165 | 809.5 K to 660.2 K (-18.44 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 10,000 | 70,300 | 59,214 | |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 5,257 | 36,957 | 69,214 | |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 4,743 | 16,316 | 0 | |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 85.00 | 10,000 | 850,000 | 69,504 | 79.5 K to 69.5 K (-12.58 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 10,000 | 70,300 | 79,504 | 69.5 K to 79.5 K (+14.39 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 84.00 | 354 | 29,737 | 69,504 | 69.9 K to 69.5 K (-0.51 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 83.51 | 3,203 | 267,486 | 69,858 | 73.1 K to 69.9 K (-4.38 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 82.52 | 1,700 | 140,282 | 73,061 | 74.8 K to 73.1 K (-2.27 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 5,257 | 36,957 | 74,761 | 69.5 K to 74.8 K (+7.56 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 84.02 | 443 | 37,220 | 69,504 | 69.9 K to 69.5 K (-0.63 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 83.50 | 2,800 | 233,803 | 69,947 | 72.7 K to 69.9 K (-3.85 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 82.55 | 1,500 | 123,825 | 72,747 | 74.2 K to 72.7 K (-2.02 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 4,743 | 16,316 | 74,247 | 69.5 K to 74.2 K (+6.82 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 5,832 | 20,062 | 0 | |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 20,000 | 68,800 | 5,832 | |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 86.93 | 900 | 78,234 | 87,179 | 88.1 K to 87.2 K (-1.02 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 86.08 | 3,132 | 269,603 | 88,079 | 91.2 K to 88.1 K (-3.43 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 85.35 | 1,800 | 153,634 | 91,211 | 93 K to 91.2 K (-1.94 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 5,832 | 20,062 | 93,011 | 87.2 K to 93 K (+6.69 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 84.01 | 1,439 | 120,886 | 87,179 | 88.6 K to 87.2 K (-1.62 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 83.52 | 12,461 | 1,040,768 | 88,618 | 101.1 K to 88.6 K (-12.33 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.53 | 6,100 | 503,439 | 101,079 | 107.2 K to 101.1 K (-5.69 %) |
| Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 20,000 | 68,800 | 107,179 | 87.2 K to 107.2 K (+22.94 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 7.03 | 2,407 | 16,921 | 33,979 | |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 20,000 | 68,800 | 25,832 | |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 5,169 | 17,781 | 0 | |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 7.03 | 10,000 | 70,300 | 36,386 | |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 20,000 | 68,800 | 45,832 | |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 10,000 | 34,400 | 5,169 | |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.62 | 504 | 41,642 | 87,179 | 87.7 K to 87.2 K (-0.57 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.80 | 1,403 | 114,771 | 87,683 | 89.1 K to 87.7 K (-1.57 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.96 | 500 | 40,478 | 89,086 | 89.6 K to 89.1 K (-0.56 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 7.03 | 2,407 | 16,921 | 89,586 | 87.2 K to 89.6 K (+2.76 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.54 | 7,200 | 594,252 | 87,179 | 94.4 K to 87.2 K (-7.63 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.67 | 10,800 | 881,993 | 94,379 | 105.2 K to 94.4 K (-10.27 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.78 | 2,000 | 161,556 | 105,179 | 107.2 K to 105.2 K (-1.87 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 20,000 | 68,800 | 107,179 | 87.2 K to 107.2 K (+22.94 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.50 | 1,764 | 145,526 | 87,179 | 88.9 K to 87.2 K (-1.98 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.66 | 2,805 | 229,062 | 88,943 | 91.7 K to 88.9 K (-3.06 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.68 | 600 | 48,409 | 91,748 | 92.3 K to 91.7 K (-0.65 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 5,169 | 17,781 | 92,348 | 87.2 K to 92.3 K (+5.93 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.16 | 2,542 | 206,304 | 87,179 | 89.7 K to 87.2 K (-2.83 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.79 | 7,458 | 602,495 | 89,721 | 97.2 K to 89.7 K (-7.67 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 7.03 | 10,000 | 70,300 | 97,179 | 87.2 K to 97.2 K (+11.47 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.13 | 6,332 | 513,684 | 87,179 | 93.5 K to 87.2 K (-6.77 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.72 | 13,668 | 1,103,240 | 93,511 | 107.2 K to 93.5 K (-12.75 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 20,000 | 68,800 | 107,179 | 87.2 K to 107.2 K (+22.94 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.16 | 2,458 | 199,486 | 87,179 | 89.6 K to 87.2 K (-2.74 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.80 | 7,542 | 609,409 | 89,637 | 97.2 K to 89.6 K (-7.76 %) |
| Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 10,000 | 34,400 | 97,179 | 87.2 K to 97.2 K (+11.47 %) |
| Nov 13 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 4,743 | |
| Nov 13 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 79.57 | 5,000 | 397,850 | 69,504 | 74.5 K to 69.5 K (-6.71 %) |
| Nov 13 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 74,504 | 69.5 K to 74.5 K (+7.19 %) |
| Nov 13 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 82.14 | 2,100 | 172,498 | 809,465 | 811.6 K to 809.5 K (-0.26 %) |
| Nov 13 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 81.59 | 11,118 | 907,118 | 811,565 | 822.7 K to 811.6 K (-1.35 %) |
| Nov 13 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 80.11 | 29,782 | 2,385,776 | 822,683 | 852.5 K to 822.7 K (-3.49 %) |
| Nov 06 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 21.15 | 33,793 | 714,722 | 96,651 | |
| Nov 06 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 22.00 | 36,957 | 813,054 | 0 | |
| Nov 06 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 14.37 | 10,069 | 144,692 | 0 | |
| Nov 06 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 79.00 | 33,793 | 2,669,647 | 185,674 | 219.5 K to 185.7 K (-15.40 %) |
| Nov 06 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 21.15 | 33,793 | 714,722 | 219,467 | 185.7 K to 219.5 K (+18.20 %) |
| Nov 06 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 79.00 | 36,957 | 2,919,603 | 185,674 | 222.6 K to 185.7 K (-16.60 %) |
| Nov 06 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 22.00 | 36,957 | 813,054 | 222,631 | 185.7 K to 222.6 K (+19.90 %) |
| Nov 06 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 79.00 | 10,069 | 795,451 | 185,674 | 195.7 K to 185.7 K (-5.14 %) |
| Nov 06 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 14.37 | 10,069 | 144,692 | 195,743 | 185.7 K to 195.7 K (+5.42 %) |